Garry Chernenko

1.7k total citations · 1 hit paper
19 papers, 1.4k citations indexed

About

Garry Chernenko is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Garry Chernenko has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Garry Chernenko's work include Heat shock proteins research (7 papers), Stroke Rehabilitation and Recovery (2 papers) and DNA Repair Mechanisms (2 papers). Garry Chernenko is often cited by papers focused on Heat shock proteins research (7 papers), Stroke Rehabilitation and Recovery (2 papers) and DNA Repair Mechanisms (2 papers). Garry Chernenko collaborates with scholars based in Canada, United States and Denmark. Garry Chernenko's co-authors include Dale Corbett, Jeff Biernaskie, Michelle Ploughman, Max S. Cynader, Shirley Granter‐Button, Budd A. Tucker, Karen M. Mearow, Shou‐Ching Tang, Alan Pater and Zhihu Ding and has published in prestigious journals such as Science, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Garry Chernenko

19 papers receiving 1.4k citations

Hit Papers

Efficacy of Rehabilitative Experience Declines with Time ... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Chernenko Canada 13 410 406 357 317 218 19 1.4k
Alexandre R. Carter United States 10 261 0.6× 217 0.5× 227 0.6× 308 1.0× 228 1.0× 17 1.0k
Tracy D. Farr Germany 24 98 0.2× 305 0.8× 447 1.3× 267 0.8× 188 0.9× 46 1.5k
Kai Diederich Germany 19 99 0.2× 186 0.5× 525 1.5× 258 0.8× 137 0.6× 47 1.2k
Craig E. Brown Canada 23 145 0.4× 632 1.6× 833 2.3× 911 2.9× 433 2.0× 40 2.3k
Noriyuki Higo Japan 20 135 0.3× 252 0.6× 334 0.9× 378 1.2× 254 1.2× 62 1.1k
Christoph Redecker Germany 28 193 0.5× 571 1.4× 993 2.8× 1.1k 3.5× 460 2.1× 73 2.6k
Gergely Silasi Canada 23 84 0.2× 232 0.6× 339 0.9× 404 1.3× 407 1.9× 37 1.6k
Pratik Y. Chhatbar United States 16 310 0.8× 97 0.2× 436 1.2× 211 0.7× 365 1.7× 32 1.2k
Chuansong Wang United States 15 81 0.2× 559 1.4× 134 0.4× 324 1.0× 161 0.7× 20 1.7k
Marco Cursi Italy 21 77 0.2× 327 0.8× 339 0.9× 380 1.2× 710 3.3× 61 1.8k

Countries citing papers authored by Garry Chernenko

Since Specialization
Citations

This map shows the geographic impact of Garry Chernenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Chernenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Chernenko more than expected).

Fields of papers citing papers by Garry Chernenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Chernenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Chernenko. The network helps show where Garry Chernenko may publish in the future.

Co-authorship network of co-authors of Garry Chernenko

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Chernenko. A scholar is included among the top collaborators of Garry Chernenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Chernenko. Garry Chernenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chernenko, Garry, et al.. (2020). FN1 mRNA expression of fibronectin 1 and distribution of fibronectin-associated leukocytes in humans with chronic diffuse liver diseases. SHILAP Revista de lepidopterología. 11(2). 200–206. 5 indexed citations
2.
Malá, Hana, et al.. (2009). The Effects of Repeated Rehabilitation “Tune-Ups” on Functional Recovery After Focal Ischemia in Rats. Neurorehabilitation and neural repair. 23(9). 886–894. 24 indexed citations
3.
Ploughman, Michelle, Shirley Granter‐Button, Garry Chernenko, et al.. (2007). Exercise intensity influences the temporal profile of growth factors involved in neuronal plasticity following focal ischemia. Brain Research. 1150. 207–216. 139 indexed citations
4.
Windle, Victoria, Garry Chernenko, Michelle Ploughman, et al.. (2007). Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke. Neuroscience. 146(1). 31–40. 109 indexed citations
5.
Ploughman, Michelle, Shirley Granter‐Button, Garry Chernenko, et al.. (2005). Endurance exercise regimens induce differential effects on brain-derived neurotrophic factor, synapsin-I and insulin-like growth factor I after focal ischemia. Neuroscience. 136(4). 991–1001. 150 indexed citations
6.
Tang, Shou-Ching, Sean T. Murphy, Garry Chernenko, et al.. (2004). BAG-1 Expression Correlates with Bcl-2, p53, Differentiation, Estrogen and Progesterone Receptors in Invasive Breast Carcinoma. Breast Cancer Research and Treatment. 84(3). 203–213. 28 indexed citations
7.
Biernaskie, Jeff, Garry Chernenko, & Dale Corbett. (2004). Efficacy of Rehabilitative Experience Declines with Time after Focal Ischemic Brain Injury. Journal of Neuroscience. 24(5). 1245–1254. 501 indexed citations breakdown →
8.
Chen, Jun, et al.. (2003). Antisense BAG-1 sensitizes HeLa cells to apoptosis by multiple pathways. Biochemical and Biophysical Research Communications. 312(3). 585–591. 18 indexed citations
10.
11.
Murphy, S., et al.. (2001). Prognostic significance of BAG-1 expression in nonsmall cell lung cancer. International Journal of Cancer. 95(5). 317–322. 41 indexed citations
12.
Ding, Zhihu, Xiaolong Yang, Garry Chernenko, Shou‐Ching Tang, & Alan Pater. (2000). Human papillomavirus type 16-immortalized endocervical cells selected for resistance to cisplatin are malignantly transformed and have a multidrug resistance phenotype. International Journal of Cancer. 87(6). 818–823. 12 indexed citations
13.
Murphy, Sean T., et al.. (2000). Prognostic significance of BAG-1 expression in non-small cell lung cancer. Lung Cancer. 29(1). 179–179. 5 indexed citations
14.
Tang, Shou-Ching, et al.. (1999). Expression of BAG-1 in Invasive Breast Carcinomas. Journal of Clinical Oncology. 17(6). 1710–1710. 71 indexed citations
15.
Yang, Xiaolong, Garry Chernenko, Yawei Hao, et al.. (1998). Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells. Oncogene. 17(8). 981–989. 123 indexed citations
16.
Chernenko, Garry, et al.. (1991). The Acute Pancreatotoxic Effects of the Plant Nitrile 1-Cyano-2-hydroxy-3-butene. Pancreas. 6(2). 168–174. 8 indexed citations
17.
Chernenko, Garry, et al.. (1986). Light Microscopic Autoradiography Followed by Electron Microscopy. Stain Technology. 61(5). 319–321. 1 indexed citations
18.
Cynader, Max S. & Garry Chernenko. (1976). Abolition of Direction Selectivity in the Visual Cortex of the Cat. Science. 193(4252). 504–505. 106 indexed citations
19.
Chernenko, Garry, et al.. (1972). Activity of deoxyribonucleases from functionally and morphologically different regions and tissues of the brain. Bulletin of Experimental Biology and Medicine. 73(5). 527–528. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026